rs371390356

Variant summary

Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong

The NM_006567.5(FARS2):​c.754G>A​(p.Ala252Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000102 in 1,597,432 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A252P) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000039 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00011 ( 0 hom. )

Consequence

FARS2
NM_006567.5 missense

Scores

19

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.776

Publications

1 publications found
Variant links:
Genes affected
FARS2 (HGNC:21062): (phenylalanyl-tRNA synthetase 2, mitochondrial) This gene encodes a protein that transfers phenylalanine to its cognate tRNA. This protein localizes to the mitochondrion and plays a role in mitochondrial protein translation. Mutations in this gene can cause combined oxidative phosphorylation deficiency 14 (Alpers encephalopathy). Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]
FARS2 Gene-Disease associations (from GenCC):
  • metabolic disease
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
  • combined oxidative phosphorylation defect type 14
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • hereditary spastic paraplegia 77
    Inheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • Leigh syndrome
    Inheritance: AR Classification: MODERATE Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -4 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.03278613).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FARS2NM_006567.5 linkc.754G>A p.Ala252Thr missense_variant Exon 3 of 7 ENST00000274680.9 NP_006558.1 O95363

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FARS2ENST00000274680.9 linkc.754G>A p.Ala252Thr missense_variant Exon 3 of 7 1 NM_006567.5 ENSP00000274680.4 O95363
FARS2ENST00000324331.10 linkc.754G>A p.Ala252Thr missense_variant Exon 3 of 7 1 ENSP00000316335.5 O95363
FARS2ENST00000445533.1 linkc.142G>A p.Ala48Thr missense_variant Exon 1 of 3 3 ENSP00000392525.1 Q5JRF7
FARS2ENST00000648580.1 linkn.754G>A non_coding_transcript_exon_variant Exon 3 of 9 ENSP00000497889.1 A0A3B3ITR6

Frequencies

GnomAD3 genomes
AF:
0.0000395
AC:
6
AN:
151982
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000882
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000163
AC:
4
AN:
245304
AF XY:
0.0000151
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000356
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000109
AC:
157
AN:
1445450
Hom.:
0
Cov.:
31
AF XY:
0.000109
AC XY:
78
AN XY:
718380
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33106
American (AMR)
AF:
0.00
AC:
0
AN:
43536
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25752
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39408
South Asian (SAS)
AF:
0.00
AC:
0
AN:
82240
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52992
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5492
European-Non Finnish (NFE)
AF:
0.000133
AC:
147
AN:
1103336
Other (OTH)
AF:
0.000168
AC:
10
AN:
59588
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.467
Heterozygous variant carriers
0
8
15
23
30
38
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000395
AC:
6
AN:
151982
Hom.:
0
Cov.:
32
AF XY:
0.0000404
AC XY:
3
AN XY:
74228
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41362
American (AMR)
AF:
0.00
AC:
0
AN:
15262
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5198
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10520
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000882
AC:
6
AN:
68026
Other (OTH)
AF:
0.00
AC:
0
AN:
2088
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.458
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000141
Hom.:
0
Bravo
AF:
0.0000378
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.0000165
AC:
2

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Combined oxidative phosphorylation defect type 14 Uncertain:1
Dec 16, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 252 of the FARS2 protein (p.Ala252Thr). This variant is present in population databases (rs371390356, gnomAD 0.004%). This variant has not been reported in the literature in individuals affected with FARS2-related conditions. ClinVar contains an entry for this variant (Variation ID: 473316). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt FARS2 protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.059
BayesDel_addAF
Benign
-0.42
T
BayesDel_noAF
Benign
-0.74
CADD
Benign
0.13
DANN
Benign
0.64
DEOGEN2
Benign
0.047
T;T;T
Eigen
Benign
-1.8
Eigen_PC
Benign
-1.7
FATHMM_MKL
Benign
0.0092
N
LIST_S2
Benign
0.43
.;T;T
M_CAP
Benign
0.0031
T
MetaRNN
Benign
0.033
T;T;T
MetaSVM
Benign
-0.97
T
MutationAssessor
Benign
-0.26
N;N;.
PhyloP100
0.78
PrimateAI
Benign
0.31
T
PROVEAN
Benign
0.030
N;N;N
REVEL
Benign
0.032
Sift
Benign
0.55
T;T;T
Sift4G
Benign
0.68
T;T;T
Polyphen
0.0
B;B;.
Vest4
0.12
MVP
0.35
MPC
0.15
ClinPred
0.012
T
GERP RS
0.18
PromoterAI
0.0023
Neutral
Varity_R
0.041
gMVP
0.36
Mutation Taster
=95/5
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs371390356; hg19: chr6-5404916; API